Skip to Main Content

Advertisement

Close

About the Press
For Librarians
Rights & Permissions
Books
JCB Journal of Cell Biology
JEM Journal of Experimental Medicine
JGP Journal of General Physiology
LSA Life Science Alliance

JCB

JEM

JGP

LSA

header search

search input Search input auto suggest

filter your search

Search

Advanced Search

Menu

Articles
Reviews & Opinion
Collections
- Special Collections
- Special Issues
Email Alerts
About
Submit

Skip Nav Destination

Article| April 15 1993

Correction

Author and Article Information

Online ISSN: 1540-8140

Print ISSN: 0021-9525

1993

J Cell Biol (1993) 121 (2): 479.

https://doi.org/10.1083/jcb.121.2.479

Connected Content

This article has been corrected Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.

Standard View
Views
Open the PDF for in another window
Share
- Facebook
- Twitter
- LinkedIn
- Email
Tools
- Get Permissions
- Cite
Search Site

Citation

Correction . J Cell Biol 15 April 1993; 121 (2): 479. doi: https://doi.org/10.1083/jcb.121.2.479

Download citation file:

Ris (Zotero)
Reference Manager
EasyBib
Bookends
Mendeley
Papers
EndNote
RefWorks
BibTex

toolbar search

toolbar search

search input Search input auto suggest

filter your search

Search

Advanced Search

This content is only available as a PDF.

View Original Article

1993

Article PDF first page preview

Article PDF first page preview

Article PDF first page preview

Related & Metrics

Data & Figures

Contents

Volume 121, Issue 2

15 April 1993

Previous Article

Supplements

References

Related & Metrics

60 Views

View Metrics

×

Suggested Content

Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.

The glycoprotein GP130 governs the surface presentation of the G protein–coupled receptor APLNR

Progressive stages of "transdifferentiation" from epidermal to mesenchymal phenotype induced by MyoD1 transfection, 5-aza-2'-deoxycytidine treatment, and selection for reduced cell attachment in the human keratinocyte line HaCaT.

Email alerts

Complete Issue Alert

Daily Publication Alert

Connected Content

Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.

Advertisement

Newest Articles
Current Issue
Archive
Email Alerts
Submit a Manuscript
Instructions for Authors
For Librarians
About JCB
Editors & Staff
Policies & Permissions
Accessibility Statement
Advertise
Contact
Newsroom
Privacy Policy
Facebook
X/Twitter
Instagram
YouTube
RSS Feeds

Facebook
X/Twitter
Instagram
YouTube

Online ISSN 1540-8140
Print ISSN 0021-9525

This Feature Is Available To Subscribers Only

Sign In or Create an Account